Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1702123/000106299324001200/form6k.htm
May 2024
May 2024
April 2024
April 2024
February 2024
February 2024
February 2024
January 2024
Please wait while we load the requested 6-K report or click the link below:
https://last10k.com/sec-filings/report/1702123/000106299324001200/form6k.htm
Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Cardiol Therapeutics Inc..
Cardiol Therapeutics Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2024 10-K Annual Report includes:
Material Contracts, Statements, Certifications & more
Cardiol Therapeutics Inc. provided additional information to their SEC Filing as exhibits
Ticker: CRDL
CIK: 1702123
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001062993-24-001200
Submitted to the SEC: Wed Jan 24 2024 7:29:56 AM EST
Accepted by the SEC: Wed Jan 24 2024
Period: Wednesday, January 24, 2024
Industry: Biological Products No Disgnostic Substances